Inogen Appoints Andy Reding as Chief Operating Officer

BEVERLY, Massachusetts—Inogen, Inc., a medical technology company offering respiratory products for use in the homecare setting, announced the appointment of Andy Reding to the newly created role of chief operating officer, effective Monday, July 6. Reding will be responsible for driving revenue and operational performance, aligning cross-functional priorities and helping ensure Inogen’s strategy is translated into efficient and measurable outcomes.

“As we continue to diversify Inogen’s business through new product launches and geographic expansion, we are streamlining our leadership structure to enhance execution and accelerate delivery of our strategic priorities,” said Kevin Smith, Inogen’s CEO. “Andy’s deep experience building high-performing teams and scaling complex medical technology businesses will be invaluable as we continue to drive top-line growth, advance profitability and expand the innovation pipeline.”

Reding joins Inogen with more than 30 years of leadership experience across medical technology, commercial operations, product development and healthcare reimbursement. Most recently, he served as chief commercial officer of Viant Medical, where for more than six years he led teams supporting complex medical-device design and manufacturing programs.

Reding has respiratory care experience as he served as vice president and general manager of Hillrom Respiratory Health, where he led sales, marketing, customer service, research and development, reimbursement and third-party billing. During his tenure, his team expanded the sales force, developed new products and successfully navigated Food & Drug Administration and Centers for Medicare and Medicaid Services requirements to bring products to market.

“I am honored to join Inogen at such an important time in the company’s evolution,” said Reding. “Inogen has a strong foundation, a compelling mission, and significant opportunities to expand its impact for patients and providers globally. I look forward to working with Kevin and the broader team to transform Inogen into a global respiratory care leader.”

Reding holds a Master of Business Administration from the University of South Carolina and a bachelor’s degree from Marquette University.

In connection with entering into employment with Inogen, Reding will receive an inducement equity award of restricted stock units (RSUs) covering an aggregate of 130,000 shares of Inogen’s common stock. Subject to Reding’s continued service with Inogen, one-third of the RSUs will vest annually over three years.